Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Nastech's PTH Nasal Spray Lands $577M P&G Deal

Feb. 2, 2006

By Jennifer Boggs

Shares of Nastech Pharmaceutical Co. Inc. jumped 18 percent Wednesday on news of a potential $577 million deal with Procter & Gamble Pharmaceuticals Inc. to develop Nastech's nasal spray for osteoporosis. (BioWorld Today)

Nastech's PTH Nasal Spray Lands $577M P&G Deal

Feb. 2, 2006

By Jennifer Boggs

Shares of Nastech Pharmaceutical Co. Inc. jumped 18 percent Wednesday on news of a potential $577 million deal with Procter & Gamble Pharmaceuticals Inc. to develop Nastech's nasal spray for osteoporosis. (BioWorld Today)

Gilead Beats Consensus; Truvada Sales Fall Short

Feb. 1, 2006

By Jennifer Boggs

Gilead Beats Consensus; Truvada Sales Fall Short

Feb. 1, 2006

By Jennifer Boggs

Altus Prices $105M IPO; Funds Earmarked For Phase III Study

Jan. 27, 2006

By Jennifer Boggs

Altus Prices $105M IPO; Funds Earmarked For Phase III Study

Jan. 27, 2006

By Jennifer Boggs

Targeted Genetics Trims Staff, Cash Burn To Focus On Clinic

Jan. 26, 2006

By Jennifer Boggs

Targeted Genetics Trims Staff, Cash Burn To Focus On Clinic

Jan. 26, 2006

By Jennifer Boggs

VC Financing Steady In 2005; Investors Favoring Late Stage

Jan. 25, 2006

By Jennifer Boggs

Curis, Genentech Stumble In Phase I Trial Of Cancer Drug

Jan. 25, 2006

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...